As of
Aug 14, 2026
2 days ago
ABT Equity Research — HOLD — August 2026
Abbott Laboratories (ABT) Stock Analysis
Research note — not an order or personalized advice.
Health Care
Desk command · ABT
12M
HOLD
Tactical
HOLD
PM
HOLD
Desk
Full
QC
Pass
Risk not statedInvalidation not stated
Research note — not a trade. This packet is an equity-research record. It is not an order, fill, best-execution instruction, or personalized investment advice.
ABT note · Aug 14, 2026
25 min
Catalyst watch
ABT's current public narrative is "steady, consistent, benchmark-grade" — the name peers get measured against, not the week's flashpoint. That is a constructive but low-volatility positioning.
Price chart · ABT
TradingView context — not part of the rating contract.
Tactical process check · 5D
—Neutral (HOLD unscored)Peer 77pExpandCollapse
Tactical process check · 5D
—Neutral (HOLD unscored)Peer 77p
Grading rule: ages the trader TACTICAL_RATING over 5 close-to-close sessions. BUY/OVERWEIGHT is Correct when the path is > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. This is not a 12-month thesis grade · context vs SPY. Scorecard computed 2026-08-15T18:08:47.393499+00:00.
5D move
—
2026-08-14 → awaiting
Outcome
Neutral (HOLD unscored)
5D trend
+3.19%
Vol (20D ann.)
+20.01%
vs SPY: +2.79%
Close 111.25 → — (USD, vendor closes)
Publish QC
passedExpandCollapse
Publish QC
passed
Pipeline fingerprint 4ce21d14d87e1d20
Trace b6ff9428…
No QC issues recorded.